Ofri Mosenzon

2 ta ish

Hebrew University of Jerusalem

1. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

   Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca +17

   Maqola20183 iqtibos

   ABIABI:AkademIndex/2026.other.282509

2. Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk

   Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald +10

   Maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.679649